Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

FDA recall notice · announced June 29, 2016 · Attix Pharmaceuticals

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Reason for recall

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Notes

Distribution: CO
Lot/code information: Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017
Quantity: N/A
Status: Terminated
Products in this recall event:
- Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada (D-1047-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.